Showing 251-260 of 3281 results for "".
- Novan Awarded Contract by BARDA to Develop a Medical Countermeasure for Thermal Burnshttps://practicaldermatology.com/news/20130829-novan_awarded_contract_by_barda_to_develop_a_medical_countermeasure_for_thermal_burns/2459472/
- Valeant Pharmaceuticals to Acquire Bausch + Lombhttps://practicaldermatology.com/news/20130528-valeant_pharmaceuticals_to_acquire_bausch__lomb/2459529/
- CeraVe Launches Seven New Sunscreens with Barrier-Repairing Ceramideshttps://practicaldermatology.com/news/20130225-cerave_launches_seven_new_sunscreens_with_barrier-repairing_ceramides/2459609/Seven newCeraVe sunscreening products are now available in the Sun Protection aisle at drugstores and mass market retailers nationwide. The CeraVe Sun Care line, developed with dermatologists, includes products for the face and body with various applications offe
- Galderma Acquires Spirighttps://practicaldermatology.com/news/20121213-galderma_acquires_spirig/2459659/Galderma Pharma S.A. and Spirig Pharma A.G. entered into a definitive agreement under which Galderma will acquire Spirig. Spirig's products treat conditions such as solar damage, skin barrier function impairment, and actinic keratosis. Leading br
- Olumiant Gains FDA Approval for Severe Alopecia Areata in Patients 12 and Olderhttps://practicaldermatology.com/news/olumiant-gains-fda-approval-for-severe-alopecia-areata-in-patients-12-and-older/2488595/The FDA has approved Eli Lilly and Company’s Olumiant (baricitinib) for patients aged 12 years and older with severe alopecia areata (AA), expanding the oral Janus kinase (JAK) inhibitor’s US indication to adolescents, according to an announcement from the manufacturer. The
- Report: Estimated 4.7 Million Americans Diagnosed With NMSC Annuallyhttps://practicaldermatology.com/news/report-estimated-47-million-americans-diagnosed-with-nmsc-annually/2488474/A new analysis from SkinCure Oncology estimates that 4.7 million Americans are diagnosed with nonmelanoma skin cancer (NMSC) each, approximately 42% higher than a commonly cited estimate based on 2012 data.
- AI Analysis Maps Environmental and Immune Signatures in Pediatric ADhttps://practicaldermatology.com/news/ai-analysis-maps-environmental-and-immune-signatures-in-pediatric-atopic-dermatitis/2488367/A machine learning (ML)-based analysis of environmental, immune, and transcriptomic data identified distinct protective and susceptibility clusters associated with pediatric atopic dermatitis (AD) among AmaXhosa children in South Africa. Published in PLoS Medicine, the observation
- PCA SKIN Launches Microbiome-Focused Acne Control Cleanserhttps://practicaldermatology.com/news/pca-skin-launches-microbiome-focused-acne-control-cleanser/2488268/PCA SKIN has launched Acne Control Prebiotic Gel Cleanser, a new daily cleanser formulated to address acne while supporting the skin barrier and microbiome, according to information provided by the company. The cleanser, laun
- Medical Creators Produce Higher-Quality Alopecia Areata Content on Social Media: Studyhttps://practicaldermatology.com/news/medical-creators-produce-higher-quality-alopecia-areata-content-on-social-media/2488252/A cross-sectional study of alopecia areata content on 3 major Chinese social media platforms found that video quality, reliability, and adherence to clinical guidance varied substantially by platform and creator background. Investigators evaluated 111 high-engagement educational videos ide
- Injectors Report Favorable Ergonomics With HA Filler Syringe Add-onhttps://practicaldermatology.com/news/injectors-report-favorable-ergonomics-with-ha-filler-syringe-add-on/2488229/A simulated-use study found that aesthetic healthcare professionals reported high levels of comfort, satisfaction, and perceived ergonomics when using an investigational add-on device designed for prefilled hyaluronic acid (HA) filler syringes. Study researchers evaluated a redesigned back